Atypical Teratoid Rhabdoid Tumor
|
0.800 |
SomaticCausalMutation
|
disease |
ORPHANET |
|
|
|
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Atypical teratoid/rhabdoid tumor (AT/RT) is a rhabdoid tumor of the central nervous system comprising a mixture of small round cells and mesenchymal and/or epithelial elements, showing mutation of the SMARCB1 gene or SMARCA4 gene.
|
23880166 |
2013 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
AT/RTs are characterized by biallelic inactivating mutations of the gene SMARCB1 in 98% of patients; these mutations may serve as molecular markers for residual tumor cell detection in liquid biopsies.
|
25016934 |
2014 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Atypical teratoid/rhabdoid tumor (AT/RT) is a malignant tumor that is commonly associated with biallelic alterations of SMARCB1.
|
28731921 |
2017 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
SMARCB1 inactivation is a well-established trigger event in atypical teratoid/rhabdoid tumor.
|
30169623 |
2018 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A consistent fraction of cases carries de-novo SMARCB1/INI1 constitutional mutations in the setting of the "rhabdoid tumor predisposition syndrome" and the outcome is worst in infant syndromic ATRT patients.
|
23510391 |
2013 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A mutation or deletion in the INI1 gene occurs in the majority of AT/RT tumors.
|
16195799 |
2005 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Abnormalities of SMARCB1 (INI1), which encodes a member of the SWI/SNF pathway, are found in neoplasms with rhabdoid morphology, such as malignant rhabdoid tumour of the kidney and atypical teratoid/rhabdoid tumour of the central nervous system.
|
27656868 |
2017 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
All 4 poorly differentiated chordomas and all AT/RTs lacked nuclear expression of SMARCB1/INI1, while the 10 typical chordomas maintained strong nuclear SMARCB1/INI1 immunoreactivity.
|
21057957 |
2010 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
Amplification of the miRNA cluster at 19q13.42 has been identified previously as a genetic hallmark for ETMR, but an immunohistochemistry-based assay for clinical routine diagnostics [such as INI-1 for atypical teratoid rhabdoid tumor (AT/RT)] is still lacking.
|
23161096 |
2012 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
An atypical teratoid-rhabdoid tumor was ruled out due to the presence of the INI1-protein.
|
24131750 |
2014 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
As expected, INI1 expression was lacking in CHLA-266 (AT/RT).
|
22120608 |
2012 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
Aside from loss of function mutations in the SMARCB1 (BAF47/INI1/SNF5) chromatin remodeling gene, little is known of other molecular drivers of AT/RT.
|
25638158 |
2015 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
Atypical teratoid/rhabdoid tumors (AT/RTs) are highly aggressive pediatric brain tumors characterized by the presence of rhabdoid cells and negative immunostaining for INI1 (BAF47).
|
19220299 |
2010 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Both components shared the same BRAF mutation, supporting their common origin, and hence the case was speculated as an AT/RT arising in the setting of a PXA by secondary genetic change of inactivation of INI1.
|
28502320 |
2018 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
Collectively, SMARCB1-deficient hPSCs offer the human models for AT/RT, which uncover the role of the activated ESC-like signature in the poor prognosis and unique histology of AT/RT.
|
30840885 |
2019 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Consistent loss of SMARCB1 nuclear expression has been considered as the hallmark abnormality for both subtypes, a feature shared with atypical teratoid/rhabdoid tumor of infancy (ATRT).
|
24585572 |
2014 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.
|
10521299 |
1999 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
|
15981100 |
2005 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
Direct DNA sequencing showed no INI1 sequence alternation in 3 of 4 AT/RTs.
|
22020042 |
2012 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1.
|
19124645 |
2009 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene.
|
10739763 |
2000 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
For example, INI-1 immunohistochemistry has assisted in identifying several previously unrecognized cases of rhabdoid cell-poor atypical teratoid rhabdoid tumor (ATRT).
|
20919607 |
2010 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
MGD |
Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
|
16099835 |
2005 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
|
16099835 |
2005 |